Avita Medical Ltd - Asset Resilience Ratio
Avita Medical Ltd (RCEL) has an Asset Resilience Ratio of 14.08% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See RCEL net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (1999–2025)
This chart shows how Avita Medical Ltd's Asset Resilience Ratio has changed over time. For the complete balance sheet picture, see Avita Medical Ltd total assets.
Liquid Assets Composition Over Time
This chart breaks down Avita Medical Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. Explore RCEL long-term investment intensity to see how much of total assets are deployed in long-term investments.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $7.94 Million | 14.08% |
| Total Liquid Assets | $7.94 Million | 14.08% |
Asset Resilience Insights
- Moderate Liquidity: Avita Medical Ltd has 14.08% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company has significant short-term investments, indicating active treasury management.
Avita Medical Ltd Industry Peers by Asset Resilience Ratio
Compare Avita Medical Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
L&C Bio Co. Ltd
KQ:290650 |
Medical Devices | 2.14% |
|
Cochlear Ltd
AU:COH |
Medical Devices | 9.76% |
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Medacta Group SA
SW:MOVE |
Medical Devices | 0.86% |
|
Sinocare Inc
SHE:300298 |
Medical Devices | 3.53% |
|
COPLAND ROAD CAPITAL NEW
F:A2P |
Medical Devices | 0.00% |
|
Zhejiang Orient Gene Biotech Co Ltd
SHG:688298 |
Medical Devices | 2.82% |
|
Shanghai Kinetic Medical Co
SHE:300326 |
Medical Devices | 28.89% |
Annual Asset Resilience Ratio for Avita Medical Ltd (1999–2025)
The table below shows the annual Asset Resilience Ratio data for Avita Medical Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 14.08% | $7.94 Million | $56.39 Million | -13.31pp |
| 2024-12-31 | 27.39% | $21.84 Million | $79.71 Million | -32.57pp |
| 2023-12-31 | 59.96% | $66.94 Million | $111.64 Million | -2.30pp |
| 2022-12-31 | 62.26% | $61.18 Million | $98.26 Million | +36.70pp |
| 2021-12-31 | 25.56% | $29.65 Million | $116.02 Million | -- |
| 2020-12-31 | 0.00% | $0.00 | $82.46 Million | -- |
| 2019-12-31 | 0.00% | $0.00 | $25.78 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $23.00 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $7.67 Million | -- |
| 2015-12-31 | 6.24% | $537.05K | $8.60 Million | -- |
| 2014-12-31 | 0.00% | $0.00 | $5.44 Million | -- |
| 2010-12-31 | 0.36% | $67.33K | $18.69 Million | -1.80pp |
| 2009-12-31 | 2.16% | $169.97K | $7.86 Million | -1.91pp |
| 2008-12-31 | 4.07% | $322.82K | $7.93 Million | +1.60pp |
| 2007-12-31 | 2.47% | $382.70K | $15.51 Million | -10.72pp |
| 2001-12-31 | 13.19% | $667.06K | $5.06 Million | -10.50pp |
| 2000-12-31 | 23.69% | $1.28 Million | $5.42 Million | -2.46pp |
| 1999-12-31 | 26.14% | $733.43K | $2.81 Million | -- |
About Avita Medical Ltd
AVITA Medical, Inc., together with its subsidiaries, operates as a therapeutic acute wound care company in the United States, Japan, the European Union, Australia, and the United Kingdom. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds and full-thickness skin defects, as well as for repigmentation of stable depigmented vitili… Read more